Skip to main content
. Author manuscript; available in PMC: 2019 Dec 1.
Published in final edited form as: Acad Radiol. 2018 Mar 27;25(12):1588–1594. doi: 10.1016/j.acra.2018.02.027

Table 2.

HCC enhancement, perfusion parameters, and pathology did not predict complete response after embolization.

CR
Av. ± SD
Non-CR
Av. ± SD
p value
HAC 0.03 ± 0.22 0.08 ± 0.29 0.45
PVC 0.44 ± 0.27 0.31 ± 0.41 0.14
AEF 0.74 ± 0.25 0.94 ± 0.83 0.21
Arterial phase enhancement (HU) 44 ± 17 45 ± 36 0.86
Portal venous phase enhancement (HU) 60 ± 15 53 ± 20 0.13
Moderate to poorly differentiated 12/16 20/28 1.0
MVI 5/25 4/29 0.72